Survivorship Research: Past, Present, and Future

  • Julia H. Rowland


In 1884, an official ceremony was held and the cornerstone laid for an ornate and turreted building in New York City that would for many years house the first cancer treatment center in the country. The site, located on the upper west side of Central Park, then a virtual wilderness area on the larger island of Manhattan, was selected because the belief at the time was that cancer was contagious. The rounded design of the towers, where patient beds were to be located, was intended to discourage the risk of germs, which were thought to lurk in corners. Named The New York Cancer Hospital, this institution would later be moved in 1948 to its current east side location where it was, until 1960, called the Memorial Hospital for Cancer and Allied Diseases. The history of this leading center for cancer care and research, known today as the Memorial Sloan-Kettering Cancer Center, a sprawling multisite enterprise, is illustrative of where we have come in viewing cancer.1


Breast Cancer Cancer Survivor Clin Oncol Childhood Cancer Posttraumatic Growth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A History of Commitment: 1884-Today. New York: Memorial Sloan-Kettering Cancer Center, Public Affairs Department booklet, 1994.Google Scholar
  2. 2.
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer (Phila) 2004;101:3–27.PubMedCrossRefGoogle Scholar
  3. 3.
    Cancer Facts and Figures 2004. Atlanta, GA: American Cancer Society, 2004.Google Scholar
  4. 4.
    D’Angio GJ. Pediatric cancer in perspective: cure is not enough. Cancer (Phila) 1975;35:866–870.PubMedCrossRefGoogle Scholar
  5. 5.
    Meadows AT, D’Angio GJ, Evans AE, et al. Oncogenesis and other late effects of cancer treatment in children. Radiology 1975;114:175–180.PubMedGoogle Scholar
  6. 6.
    Koocher G, O’Malley J. The Damocles Syndrome. New York: McGraw-Hill, 1981.Google Scholar
  7. 7.
    Holland JC. Historical overview. In: Holland JC, Rowland JH (eds). Handbook of Psychooncology: Psychological Care of the Patient with Cancer. Oxford: Oxford University Press, 1989:3–12.Google Scholar
  8. 8.
    Dolbeault S, Szporn A, Holland JC. Psycho-oncology: where have we been? Where are we going? Eur J Cancer 1999;35:1554–1558.PubMedCrossRefGoogle Scholar
  9. 9.
    Oken D. What to tell cancer patients: a study of medical attitudes. JAMA 1961;175:1120–1128.PubMedGoogle Scholar
  10. 10.
    Novack DH, Plumer R, Smith RL, et al. Changes in physicians’ attitudes toward telling the cancer patient. JAMA 1979;241:897–900.PubMedCrossRefGoogle Scholar
  11. 11.
    Mystakidou K, Parpa E, Tsilila E, et al. Cancer information disclosure in different cultural contexts. Support Care Cancer 2004;12(3):147–154.PubMedCrossRefGoogle Scholar
  12. 12.
    Surbone A. Persisting differences in truth telling throughout the world. Support Care Cancer 2004;12(3):143–146.PubMedCrossRefGoogle Scholar
  13. 13.
    Wang S-Y, Chen C-H, Chen Y-S, Huang H-L. The attitude toward truth telling of cancer in Taiwan. J Psychosom Res 2004;57:53–58.PubMedCrossRefGoogle Scholar
  14. 14.
    Holland JC. IPOS Sutherland Memorial Lecture: An international perspective on the development of psychosocial oncology: overcoming cultural and attitudinal barriers to improve psychosocial care. Psycho-Oncology 2004;13(7):445–459.PubMedCrossRefGoogle Scholar
  15. 15.
    Reuben SH (ed). Living Beyond Cancer: A European Dialogue. President’s Cancer Panel 2003–2004 Annual Report Supplement. Bethesda, MD: U.S. Department of Health and Human Services, NIH, NCI, May 2004.Google Scholar
  16. 16.
    Die-Trill M, Holland JC. A model curriculum for training in psycho-oncology. Psycho-Oncology 1995;4:169–182.CrossRefGoogle Scholar
  17. 17.
    Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale: preliminary report. Psychopharmacol Bull 1973;9:13–28.PubMedGoogle Scholar
  18. 18.
    NcNair DM, Lorr M, Droppleman R. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1971.Google Scholar
  19. 19.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.CrossRefGoogle Scholar
  20. 20.
    Endicott J. Measurement of depression in patients with cancer. Cancer (Phila) 1984;53:2243–2249.PubMedGoogle Scholar
  21. 21.
    Kathol RG, Noyes R, Williams J, et al. Diagnosing depression in patients with medical illness. Psychosomatics 1990;31(4):434–440.PubMedGoogle Scholar
  22. 22.
    Cohen-Cole SA, Brown FW, McDainel JS. Assessment of depression and grief reactions in the medically ill. In: Stoudemire A, Fogel BS (eds). Psychiatric Care of the Medical Patient. New York: Oxford University Press, 1993:53–69.Google Scholar
  23. 23.
    Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: development and validation. J Clin Oncol 1984;2(5):475–483.Google Scholar
  24. 24.
    Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990;4(5):135–138.PubMedGoogle Scholar
  25. 25.
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365–376.PubMedCrossRefGoogle Scholar
  26. 26.
    Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993;11(3):570–579.PubMedGoogle Scholar
  27. 27.
    Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985;313:270–273.PubMedCrossRefGoogle Scholar
  28. 28.
    Hoffman B (ed) National Coalition for Cancer Survivorship. A cancer survivor’s almanac. Charting your journey. Minneapolis: Chronimed Publishing, 1996:XII–XIII. http://www.canceradvocacy.orgGoogle Scholar
  29. 29.
    http://www.survivorship.cancer.govGoogle Scholar
  30. 30.
    The Nation’s Investment in Cancer Research: A plan and budget proposal for fiscal year 2004. NIH Publication No. 03-4373. Prepared by the Director, National Cancer Institute. Bethesda, MD: National Institutes of Health, USDHHS, October 2002; Hewitt M, Greenfield S, Stovall E (eds). From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press, 2006.Google Scholar
  31. 31.
    The Nation’s Investment in Cancer Research: A plan and budget proposal for fiscal year 2005. NIH Publication No. 03-5446. Prepared by the Director, National Cancer Institute. Bethesda: National Institutes of Health, USDHHS, October 2003.Google Scholar
  32. 32.
    Hewitt M, Weiner SL, Simone JV (eds). Childhood Cancer Survivorship. Improving Care and Quality of Life. Washington, DC: National Academies Press, 2003.Google Scholar
  33. 33.
    Living Beyond Cancer: Finding a New Balance. President’s Cancer Panel 2003 Annual Report. Bethesda, MD: U.S. Department of Health and Human Services, NIH, NCI, May 2004.Google Scholar
  34. 34.
    CDC, Lance Armstrong Foundation. A national action plan for cancer survivorship: advancing public health strategies. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2004.Google Scholar
  35. 35.
    Tross S, Holland JC. Psychological sequelae in cancer survivors. In: Holland JC, Rowland JH (eds). Handbook of Psychooncology: Psychological Care of the Patient with Cancer. Oxford: Oxford University Press, 1989:101–116.Google Scholar
  36. 36.
    Kornblith AB. Psychosocial adaptation of cancer survivors. In: Holland JC (ed). Psycho-Oncology. New York: Oxford University Press, 1998:223–241.Google Scholar
  37. 37.
    Meadows AT. Pediatric cancer survivors: past history and future challenges. Curr Probl Cancer 2003;27:112–126.PubMedCrossRefGoogle Scholar
  38. 38.
    Yeazel MW, Oeffinger KC, Gurney JG, et al. The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivors Study. Cancer (Phila) 2004;100:631–640.PubMedCrossRefGoogle Scholar
  39. 39.
    Spingarn ND. Hanging in There: Living Well on Borrowed Time. New York: Stein & Day, 1982.Google Scholar
  40. 40.
    Spingarn ND. The New Cancer Survivors: Living With Grace, Fighting with Spirit. Baltimore: Johns Hopkins University Press, 1999.Google Scholar
  41. 41.
    Cancer survivorship-United States, 1971–2001. MMWR 2004; 53(24):526–529; and 41a., accessed September 16, 2006.Google Scholar
  42. 42. Scholar
  43. 43.
    Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol 2004;31:128–136.PubMedCrossRefGoogle Scholar
  44. 44.
    Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58(1):82–91.PubMedGoogle Scholar
  45. 45.
    Caregiving in the U.S. A report by the National Alliance for Caregiving and AARP, 2004, Scholar
  46. 46.
    Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999;91:1480–1486.PubMedCrossRefGoogle Scholar
  47. 47.
    Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose and method of measurement. Cancer Invest 1993;11:327–336.PubMedGoogle Scholar
  48. 48.
    Sprangers MAG, Aaronson NK. The role of health care providers and others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 1992;45:743–760.PubMedCrossRefGoogle Scholar
  49. 49.
    Fromme EK, Eilers KM, Mori M, et al. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 2004;22:3485–3490.PubMedCrossRefGoogle Scholar
  50. 50.
    Sptizer QO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. J Chron Dis 1981;34:585–597.CrossRefGoogle Scholar
  51. 51.
    Padilla GV, Presant C, Grant MM, et al. Quality of Life Index for patients with cancer. Res Nurs Health 1983;6:117–126.PubMedCrossRefGoogle Scholar
  52. 52.
    Bergner M, Bobbitt RA, Careter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787–806.PubMedCrossRefGoogle Scholar
  53. 53.
    Lipscomb J, Gotay CC, Snyder CF. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, England: Cambridge University Press, 2005.Google Scholar
  54. 54.
    Ferrell BR, Dow KH, Grant M. Measurement of quality of life in cancer survivors. Qual Life Res 1995;4:523–531.PubMedCrossRefGoogle Scholar
  55. 55.
    Wyatt GK, Friedman LL. Development and testing of a quality of life model for long-term female cancer survivors. Qual Life Res 1996;5:387–394.PubMedCrossRefGoogle Scholar
  56. 56.
    Ferrans CE, Power MJ. Quality of life index: development and psychometric properties. Ann Nurs Sci 1995;8:15–24.Google Scholar
  57. 57.
    Pinto B, Eakin E, Maruyama N. Health behavior changes after a cancer diagnosis: what do we know and where do we go from here? Ann Behav Med 2000;22:38–52.PubMedGoogle Scholar
  58. 58.
    Blanchard CM, Denniston M, Baker F, et al. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav 2003;27:246–256.PubMedGoogle Scholar
  59. 59.
    Oeffinger KC, Mertens AC, Hudson MM, et al. Health care of young adult survivors of childhood cancer; a report from the Childhood Cancer Survivor Study. Ann Fam Med 2004;2:61–70.PubMedCrossRefGoogle Scholar
  60. 60.
    Holmes MD, Kroenke CH. Beyond treatment: lifestyle choices after breast cancer to enhance quality of life and survival. Womens Health Issues 2004;14:11–13.PubMedCrossRefGoogle Scholar
  61. 61.
    Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 1981;4:213–220.PubMedCrossRefGoogle Scholar
  62. 62.
    Lee-Jones C, Humphris G, Dixon R, Hatcher M. Fear of cancer recurrence: a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology 1997;6:95–105.PubMedCrossRefGoogle Scholar
  63. 63.
    Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med 2003;25(1):16–24.PubMedCrossRefGoogle Scholar
  64. 64.
    Doward LC, McKennssa SP. Evolution of quality of life assessment. In: Rajagopalan R, Sheretz EF, Anderson RT (eds). Care Management of Skin Disease: Life Quality and Economic Impact. New York: Dekker, 1997:9–33.Google Scholar
  65. 65.
    Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622–629.PubMedGoogle Scholar
  66. 66.
    Bonanno GA. Loss, trauma and human resilience. Have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol 2004;59:20–28.PubMedCrossRefGoogle Scholar
  67. 67.
    Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41:229–237.PubMedCrossRefGoogle Scholar
  68. 68.
    Bard M, Sutherland AM. The psychological impact of cancer and its treatment: IV. Adaptation to radical mastectomy. Cancer (Phila) 1955;8:656–672.PubMedCrossRefGoogle Scholar
  69. 69.
    Holmes HA, Holmes FF. After ten years, what are the handicaps and life styles of children treated for cancer? Clin Pediatr 1975;14:819–823.Google Scholar
  70. 70.
    Rieker P, Edbril SD, Garnick MB. Curative testis cancer therapy: psychosocial sequelae. J Clin Oncol 1985;3:1117–1126.PubMedGoogle Scholar
  71. 71.
    Cella DF, Tross S. Psychological adjustment to survival from Hodgkin’s disease. J Consult Clin Psychol 1986;54:616–622.PubMedCrossRefGoogle Scholar
  72. 72.
    Rapoport Y, Keritler S, Chaitchik S, et al. Psychosocial problems in head-and-neck cancer patients and their change with time since diagnosis. Ann Oncol 1993;4:69–73.PubMedGoogle Scholar
  73. 73.
    Green BL, Krupnick JL, Rowland JH, et al. Trauma history as a predictor of psychologic symptoms in women with breast cancer. J Clin Oncol 2000;18:1084–1093.PubMedGoogle Scholar
  74. 74.
    Cordova MJ, Andrykowski MA. Responses to cancer diagnosis and treatment: posttraumatic stress and posttraumatic growth. Semin Clin Neuropsychiatry 2003;8:286–296.PubMedGoogle Scholar
  75. 75.
    Lechner SC, Zakowski SG, Antoni MH, et al. Do sociodemo-graphic and disease-related variables influence benefit-finding in cancer patients? Psycho-Oncology 2003;12:491–499.PubMedCrossRefGoogle Scholar
  76. 76.
    Sears SR, Stanton AL, Danoff-Burg S. The yellow brick road and the emerald city: benefit finding, positive reappraisal coping and post-traumatic growth in women with early-stage breast cancer. Health Psychol 2003;22:487–497.PubMedCrossRefGoogle Scholar
  77. 77.
    Tomich PL, Helgeson VS. Is finding something good in the bad always good? Benefit finding among women with breast cancer. Health Psychol 2004;23:16–23.PubMedCrossRefGoogle Scholar
  78. 78.
    Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients. A meta-analysis of randomized experiments. Health Psychol 1995;14:101–108.PubMedCrossRefGoogle Scholar
  79. 79.
    Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: metaanalysis of 116 studies. Oncol Nurs Forum 1995;22:1369–1381.PubMedGoogle Scholar
  80. 80. Scholar
  81. 81.
    Rowland JH. Psycho-oncology and breast cancer: a paradigm for research and intervention. Breast Cancer Res Treat 1994;31(2–3):315–324.PubMedCrossRefGoogle Scholar
  82. 82.
    Nehl EJ, Blanchard CM, Stafford JS, et al. Research interests in the field of behavioral, psychosocial, and policy cancer research. Psycho-Oncology 2003;12:385–392.PubMedCrossRefGoogle Scholar
  83. 83.
    Aziz NM, Rowland JH. Cancer survivorship research among ethnic minority and medically underserved groups. Oncol Nurs Forum 2002;29(5):789–801.PubMedGoogle Scholar
  84. 84.
    Schottenfeld D, Robbins GF. Quality of survival among patients who have had radical mastectomy. Cancer (Phila) 1970;26:650–654.PubMedCrossRefGoogle Scholar
  85. 85.
    Li FP, Stone R. Survivors of cancer in childhood. Ann Intern Med 1976;84:551–553.PubMedGoogle Scholar
  86. 86.
    Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004;96:376–387.PubMedCrossRefGoogle Scholar
  87. 87.
    Kroenke CH, Rosner B, Chen WY, et al. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 2004;22:1849–1856.PubMedCrossRefGoogle Scholar
  88. 88.
    Andersen BL, Farrar WB, Golden-Kreutz DM, et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 2004;22:3570–3580.PubMedCrossRefGoogle Scholar
  89. 89.
    Abercrombie HC, Giese-Davis J, Sephton S, et al. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004;29:1082–1092.PubMedCrossRefGoogle Scholar
  90. 90.
    Jacobsen PB, Meade CD, Stein KD, et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 2002;20:2851–2862.PubMedCrossRefGoogle Scholar
  91. 91.
    Bovbjerg D. Psychoneuroimmunology and cancer. In: Holland JC, Rowland JH (eds). Handbook of Psychooncology. Psychological Care of the Patient with Cancer. New York: Oxford University Press, 1989:727–734.Google Scholar
  92. 92.
    Bauer-Wu SM. Psychoneuroimmunology. Part II: Mind-body interventions. Clin J Oncol Nurs 2002;6:243–246.PubMedGoogle Scholar
  93. 93.
    Antoni MH. Psychoneuroendocrinology and psychoneuroimmunology of cancer: plausible mechanisms worth pursuing? Brain Behav Immun 2003 (suppl 1):S84–S91.CrossRefGoogle Scholar
  94. 94.
    Sobel DS. The cost-effectiveness of mind-body medicine interventions. Prog Brain Res 2000;122:393–412.PubMedCrossRefGoogle Scholar
  95. 95.
    Angell KL, Kreshka MA, McCoy R, et al. Psychosocial intervention for rural women with breast cancer: the Sierra-Stanford Partnership. J Gen Intern Med 2003;18:499–507.PubMedCrossRefGoogle Scholar
  96. 96.
    Fawzy NW. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients. Cancer Nurs 1995;18:427–438.PubMedCrossRefGoogle Scholar
  97. 97.
    Gustafson DH, Hawkins RP, Boberg EW, et al. CHESS: 10 years of research and development in consumer health informatics for broad populations, including the underserved. Int J Med Inform 2002;65:169–177.PubMedCrossRefGoogle Scholar
  98. 98.
    Lierberman MA, Golant M, Giese-Davis J, et al. Electronic support groups for breast carcinoma: a clinical trial of effectiveness. Cancer (Phila) 2003;97:920–925.CrossRefGoogle Scholar
  99. 99.
    Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol 2003;13:248–266.PubMedCrossRefGoogle Scholar
  100. 100.
    Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29(4):341–350.PubMedCrossRefGoogle Scholar
  101. 101.
    Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138(5):482–487.PubMedCrossRefGoogle Scholar
  102. 102.
    Ingham J, Seidman A, Yao TJ, et al. An exploratory study of frequent pain measurement in a cancer clinical trial. Qual Life Res 1996;5:503–507.PubMedCrossRefGoogle Scholar
  103. 103.
    Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004;22:2233–2239.PubMedCrossRefGoogle Scholar
  104. 104.
    Hewitt M, Simone JV (eds) Ensuring Quality Cancer Care. Washington, DC: National Academy Press, 1999.Google Scholar
  105. 105.
    Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 1998;280:1000–1005.PubMedCrossRefGoogle Scholar
  106. 106.
    Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol 2002;20(23):4581–4590.PubMedCrossRefGoogle Scholar
  107. 107.
    Freeman HP, Reuben SH (eds) Voices of a Broken System: Real People, Real Problems. President’s Cancer Panel Report of the Chairman, 2000–2001. NIH Publication No. 03-5301. Bethesda, MD: National Institutes of Health, National Cancer Institute, December 2 2002.Google Scholar
  108. 108.
    Rowland JH, Desmond KA, Meyerowitz BE, et al. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 2000;92(17):1422–1429.PubMedCrossRefGoogle Scholar
  109. 109.
    McGregor BA, Antoni MH, Boyers A, et al. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J Psychosom Res 2004;56:1–8.PubMedCrossRefGoogle Scholar
  110. 110.
    Antoni MH. Stress Management Intervention for Women with Breast Cancer (accompanied by Therapist’s Manual and Participant’s Workbook). Washington, DC: American Psychological Association Press, 2003.Google Scholar
  111. 111.
    Courneya KS, Mackey JR, Bell GJ, et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003;21(9):1660–1668.PubMedCrossRefGoogle Scholar
  112. 112.
    Courneya KS. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc 2003;35(11):1846–1852.PubMedCrossRefGoogle Scholar
  113. 113.
    Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441–2447.PubMedCrossRefGoogle Scholar
  114. 114.
    Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors; findings from a population-based national sample. J Natl Cancer Inst 2004;96:1322–1330.PubMedCrossRefGoogle Scholar
  115. 115.
    Meyerowitz BE, Richardson J, Hudson S, Leedham B. Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull 1998;123:47–70.PubMedCrossRefGoogle Scholar
  116. 116.
    Ganz PA. Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory. Eur J Cancer 2003;39(15):2136–2141.PubMedCrossRefGoogle Scholar
  117. 117.
    Pakilit AT, Kahn BA, Petersen L, et al. Making effective use of tumor registries for cancer survivorship research. Cancer (Phila) 2001;92:1305–1314.PubMedCrossRefGoogle Scholar
  118. 118.
    Robison L. Research involving long-term survivors of childhood and adolescent cancer: methodologic considerations. Curr Probl Cancer 2003;27:212–224.PubMedCrossRefGoogle Scholar
  119. 119.
    Ward HJT, Cousens SN, Smith-Bathgate B, et al. Obstacles to conducting epidemiological research in the UK general population. BMJ 2004;329:277–279.PubMedCrossRefGoogle Scholar
  120. 120. Scholar
  121. 121. Scholar
  122. 122.,1003,_12-002303-00_18-0012404,00.aspGoogle Scholar
  123. 123.
    Loiselle CG, Bottorff JL, Butler L Degner LF. PORT: Psychosocial oncology research training: a newly funded strategic initiative in health research. Can J Nurs Res, 2004;36:159–164.PubMedGoogle Scholar
  124. 124.
    Fallowfield L, Jenkins V, Farewell V, Solis-Trapala I. Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer 2003;20:1445–1449.CrossRefGoogle Scholar
  125. 125.
    Wingo PA, Howe HL, Thun MJ, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control 2005;16:151–170.PubMedCrossRefGoogle Scholar
  126. 126.
    Lipscomb J, Donaldson MS, Arora NK, et al. Cancer outcomes Research. Natl Cancer Inst Momogr 2004;33:178–192.CrossRefGoogle Scholar
  127. 127.
    Greer S. Psycho-oncology: its aims, achievements and future tasks. Psycho-Oncology 1994;3:87–101.CrossRefGoogle Scholar
  128. 128.
    Holland JC. Psychological care of patients: psycho-oncology’s contribution. J Clin Oncol 2003;21:253s–265s.PubMedCrossRefGoogle Scholar
  129. 129.
    Greer S. Psychological intervention. The gap between research and practice. Acta Oncol 2002;41:238–243.PubMedCrossRefGoogle Scholar
  130. 130.
    Nicassio PM, Meyerowitz BE, Kerns RD. The future of health psychology interventions. Health Psychol 2004;23:132–137.PubMedCrossRefGoogle Scholar
  131. 131.
    Hewitt M, Herdman R, Holland J (eds). Meeting the Psychosocial Needs of Women with Breast Cancer. Washington, DC: National Academies Press, 2004.Google Scholar
  132. 132.
    Tesauro GM, Rowland JH, Lustig C. Survivorship resources for post-treatment cancer survivors. Cancer Pract 2002;10:277–283.PubMedCrossRefGoogle Scholar
  133. 133.
    Rowland JH. Looking beyond cure: pediatric cancer as a model. J Pediatr Psychol 2005;30:1–3.PubMedCrossRefGoogle Scholar
  134. 134.
    Mertens AC, Cotter LK, Foster BM, et al. Improving health care for adult survivors of childhood cancer: recommendations from a Delphi panel of health policy experts. Health Policy 2004;69:169–178.PubMedCrossRefGoogle Scholar
  135. 135.
    Kattlove H, Winn RJ. Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 2003;54:172–196.CrossRefGoogle Scholar
  136. 136.
    http://www.survivorshipguidelines.orgGoogle Scholar
  137. 137.
    McMurchie M. Life after cancer. Aust Fam Physician 1991;20:1444–1451.PubMedGoogle Scholar
  138. 138.
    Earle CC, Burstein JH, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003;21:1447–1451.PubMedCrossRefGoogle Scholar
  139. 139.
    Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer (Phila) 2004;101:1712–1719; 2004; epub.PubMedCrossRefGoogle Scholar
  140. 140.
    Ganz PA. What outcomes matter to patients: a physicianresearcher point of view. Med Care 2002;40(6 suppl):III-1–III-9.Google Scholar
  141. 141.
    Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives on comorbidity and cancer in older patients; approaches to expand the knowledge base. J Clin Oncol 2001;19:1147–1151.PubMedGoogle Scholar
  142. 142.
    Gatta G, Capocaccia R, Berrino F, et al., and EUROPREVAL Working Group. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol 2004;15:1136–1142.PubMedCrossRefGoogle Scholar
  143. 143.
    Earle CC, Nattinger AB, Potosky AL, et al. Identifying cancer relapse using SEER-Medicare data. Med Care 2002;40:5–81.CrossRefGoogle Scholar
  144. 144.
    Mariotto A. Surveillance Research Program, Division of Cancer Control and Population Sciences. National Cancer Institute, NIH/DHHS, Bethesda, MD. Personal communication.Google Scholar
  145. 145.
    Leigh S. The culture of survivorship. Semin Oncol Nurs 2001;17:234–235.PubMedCrossRefGoogle Scholar
  146. 146.
    Zebrack B. An advocate’s perspective on cancer survivorship. Semin Oncol Nurs 2001;17:284–287.PubMedCrossRefGoogle Scholar
  147. 147.
    Stovall E, Gesme D. Coming together to conquer cancer. J Clin Oncol 1999;17:730.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Julia H. Rowland
    • 1
  1. 1.Office of Cancer Survivorship, Division of Cancer Control and Population ScienceNational Cancer InstituteBethesdaUSA

Personalised recommendations